Li Auto Inc. Announces Unaudited Third Quarter 2022 Financial Results
December 09, 2022 03:30 ET | Li Auto Inc.
Quarterly total revenues reached RMB9.34 billion (US$1.31 billion)1Quarterly deliveries reached 26,524 vehicles BEIJING, China, Dec. 09, 2022 (GLOBE NEWSWIRE) -- Li Auto Inc. (“Li Auto” or the...
Li Auto Inc. Announces Management and Board Changes
December 09, 2022 03:29 ET | Li Auto Inc.
BEIJING, China, Dec. 09, 2022 (GLOBE NEWSWIRE) --  Li Auto Inc. (“Li Auto” or the “Company”) (Nasdaq: LI; HKEX: 2015), a leader in China’s new energy vehicle market, today announced that Mr. Yanan...
Himax Technologies, Inc. Logo
Himax WiseEye™ Solution Earns “Most Promising Product” at EE Awards Asia 2022
December 09, 2022 02:20 ET | Himax Technologies, Inc.
TAINAN, Taiwan, Dec. 09, 2022 (GLOBE NEWSWIRE) -- Himax Technologies, Inc. (Nasdaq: HIMX) (“Himax” or “Company”), a leading supplier and fabless manufacturer of display drivers and other...
Obseva Logo highresolution.jpg
ObsEva To Increase Issued Share Capital by Creating Additional Treasury Shares
December 09, 2022 01:00 ET | ObsEva SA
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – December 9, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and...
Picture1.png
Autolus Announces Pricing of Public Offering
December 08, 2022 21:11 ET | Autolus Therapeutics plc
LONDON, Dec. 08, 2022 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced...
Replimune Announces Pricing of Public Offering
December 08, 2022 21:04 ET | Replimune Group Inc
BOSTON, Dec. 08, 2022 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of a novel class of tumor-directed oncolytic...
BNGO Logo.png
Bionano Genomics Announces American Society of Hematology (ASH) Annual Meeting Presentations Featuring OGM Utility Across Blood Cancer Research Applications
December 08, 2022 20:24 ET | Bionano Genomics
A scientific workshop will feature Dr. Rashmi Kanagal-Shamanna from the University of Texas MD Anderson Cancer Center delivering a presentation on the use of emerging technologies for prognostication...
Prometheus_Biosciences_Logo.jpg
Prometheus Biosciences, Inc. Announces Pricing of Public Upsized $500 Million Offering of Common Stock
December 08, 2022 19:39 ET | Prometheus Biosciences
SAN DIEGO, Dec. 08, 2022 (GLOBE NEWSWIRE) -- Prometheus Biosciences, Inc. (Nasdaq: RXDX), a clinical-stage biotechnology company pioneering a precision medicine approach for the discovery,...
myriad_S_stacked.png
Myriad Genetics Patient Outcomes Study Shows RiskScore Leads to More Accurate Breast Cancer Risk Prediction than Standard-of-Care Risk Model
December 08, 2022 19:15 ET | Myriad Genetics, Inc.
SALT LAKE CITY, Dec. 08, 2022 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today presented results from a longitudinal study...
Grom.png
Grom Social Enterprises, Inc. Prices $5.0 Million Public Offering
December 08, 2022 18:45 ET | Grom Social Enterprises
BOCA RATON, Fla., Dec. 08, 2022 (GLOBE NEWSWIRE) -- Grom Social Enterprises, Inc. (NASDAQ: GROM) (the “Company”), today announced the pricing of a public offering of 1,415,682 units (the “Units”) at...